STOCK TITAN

Insider at company (NASDAQ: VRTX) plans 2,476-share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An affiliated shareholder has filed notice of an intended sale of 2,476 shares of common stock through Fidelity Brokerage Services LLC on or around February 17, 2026 on the NASDAQ. The filing lists an aggregate market value of $1,211,902.96 for these shares, compared with 254,034,190 shares outstanding.

The shares to be sold were acquired on February 13, 2026 through restricted stock vesting from the issuer as compensation. The notice also details prior sales in the last three months by Jonathan P. Biller, including several smaller common‑stock transactions.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the insider trading notice for VRTX disclose?

It discloses an intended sale of 2,476 common shares on NASDAQ with an aggregate market value of $1,211,902.96. The shares were recently acquired through restricted stock vesting as compensation from the issuer.

Who is the selling security holder in the recent VRTX notice?

The notice identifies Jonathan P. Biller as the person whose account the securities are to be sold. It also lists his prior three‑month common‑stock sales, including transactions on December 3, 2025 and February 11 and 13, 2026.

How many VRTX shares are planned for sale and on which exchange?

The filing states that 2,476 common shares are planned for sale with an aggregate market value of $1,211,902.96. The intended transaction is to occur on the NASDAQ through Fidelity Brokerage Services LLC.

How were the VRTX shares being sold acquired by the insider?

The shares were acquired on February 13, 2026 via a restricted stock vesting transaction from the issuer, described as compensation. The same date is listed for both the acquisition and payment, indicating a non‑cash, equity‑based award.

What recent VRTX stock sales has Jonathan P. Biller reported?

He reported three recent common‑stock sales: 347 shares on December 3, 2025 for $155,803.00, 1,925 shares on February 11, 2026 for $886,327.75, and 988 shares on February 13, 2026 for $493,012.00.

How many VRTX shares are outstanding compared with the planned sale?

The document reports 254,034,190 shares outstanding of the issuer’s common stock. The intended transaction covers 2,476 shares, and this outstanding share count serves as a baseline reference for the company’s total equity.
Vertex Pharmaceuticals Inc

NASDAQ:VRTX

VRTX Rankings

VRTX Latest News

VRTX Latest SEC Filings

VRTX Stock Data

119.47B
253.12M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON